KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)

OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)

The Company will sponsor a pre-course meeting in addition to five spotlight sessions on a variety of topics

WARSAW, Ind., Nov. 20, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that it will continue its support as a Double-Diamond sponsor of the International Pediatric Orthopedic Symposium (IPOS), taking place December 3-7 in Orlando, Florida. IPOS, a branch of the Pediatric Orthopedic Society of North America, is a leading educational meeting for pediatric orthopedic surgeons.

Mark Throdahl, President and CEO of OrthoPediatrics, commented, “We greatly value our partnership with POSNA as it provides the opportunity to continue educating and developing pediatric surgeons. Meetings such as IPOS help drive advancements in our field because of the knowledge, best practices, and training that attendees are exposed to.”

OrthoPediatrics will sponsor a pre-course entitled “Super Smash Brothers: Pediatric Elbow vs. Monkey Bars.” The course will explore various aspects of supracondylar humerus fractures. Additionally, the Company will host five workshop sessions. Covered topics will include spinal disorders, techniques for pediatric foot and ankle deformity correction, orthopedic trauma, hexapod procedures, and neuromuscular treatment.

OrthoPediatrics will highlight three recently launched systems, the two Cannulated Screw Systems and the PediFoot System as well as the newly acquired Orthex Hexapod External Fixation System, at the Company’s booth (#100 & #101) at the IPOS meeting.

Session Details:

2019 IPOS Pre-course: Super Smash Brothers: Pediatric Elbow vs. Monkey Bars

The Ultimate Boss Battle – You vs. the Posterolateral SCH 

An Interactive Extravaganza!

Details: Deep dive into supracondylar humerus fractures

Faculty: Jon Schoenecker, Chris Stutz, Brian Tompkins

Date: Tuesday, December 3, 2019 at 6:45 – 8:00pm

Shilla - A different way to think about EOS and other growing spinal disorders

Faculty: Dr. Rick McCarthy & Dr. Scott Luhmann

Date: Wednesday, December 4, 2019 at 3:20 – 4:30pm

Techniques in Pediatric Foot and Ankle Deformity Correction

Faculty: Dr. Vincent Mosca, Dr. Maryse Bouchard, and Dr. Jon Davids

Date: Wednesday, December 4, 2019 at 3:20 – 4:30pm

That wasn’t the plan, now what?!: Pediatric Orthopedic Trauma

Faculty: Dr. Alexandre Arkader, Dr. Joshua Murphy, & Dr. Scott Rosenfeld

Date: Thursday, December 4, 2019 at 4:40 – 5:50pm

Deformity Correction Surgical Planning and Software: A Novel Approach to Hexapod Procedures

Faculty: Dr. Dror Paley, Dr. Tony Cooper, Dr. Craig Robbins, & Dr. Sean Tabaie

Date: Thursday, December 5, 2019 8:00 – 9:10am

The Challenges, Decision Making, and Solutions in Treating Pediatric Neuromuscular Scoliosis

Faculty: Dr. Chris Hardesty & Dr. Jonathan Phillips

Date: Friday, December 6, 2019 at 10:20 – 11:30am

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 32 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States.

Investor Contacts

The Ruth Group

Tram Bui / Emma Poalillo

(646) 536-7035 / 7024

/

EN
20/11/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics to Participate in Upcoming Conferences

OrthoPediatrics to Participate in Upcoming Conferences WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences. Event: TD Cowen 46th Annual Health Care Conference Format: Fireside Chat Date: Tuesday, March 3, 2026Time: 1:10 pm ET Event: The Citizens Life Sciences Conference Format: Fireside Chat Date: Tuesday, March 10, 2026Time: 10:10 am ET An audio webcast of the ...

 PRESS RELEASE

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financ...

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results Record full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial resu...

 PRESS RELEASE

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Fina...

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results. Inv...

 PRESS RELEASE

OrthoPediatrics Announces Expanded Enabling Technology Market Opportun...

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older WARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System. The system is now cleared for ...

 PRESS RELEASE

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue fo...

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the fourth quarter and full year ended December...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch